Stay updated on Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial
Sign up to get notified when there's something new on the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page.

Latest updates to the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page
- Check2 days agoChange DetectedThe platform revision tag has advanced from v3.5.3 to v3.5.4, indicating a new build of the site.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page footer revision was updated from v3.5.2 to v3.5.3, indicating a minor site/record interface version change rather than an update to the clinical study information.SummaryDifference0.0%

- Check31 days agoChange DetectedReplimune, Inc. was added and the revision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check60 days agoChange DetectedHeader shows Revision: v3.5.0, replacing v3.4.3. No study details or user-facing functionality were changed.SummaryDifference0.0%

- Check74 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check96 days agoChange DetectedA new page revision tag 'Revision: v3.4.2' was added, replacing the previous 'Revision: v3.4.1'. The change appears to be a routine maintenance update without altering study details or eligibility information.SummaryDifference0.0%

Stay in the know with updates to Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cemiplimab + RP1 Combo in Advanced Squamous Skin Cancer Clinical Trial page.